E-LIB Suche - Ergebnisse für: Bourrier, A

1

DOP26 Metagenomic and metabolomic profiles in IBD: understa..:

Marius, B ; Rolhion, N ; Creusot, L...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i121-i121 , 2024

Link: https://doi.org/10.1093/..

2

On-chip sample preparation and biosensing: Can porous silic..:

, In: 2023 International Electron Devices Meeting (IEDM),

Leichle, T. ; He, Y. ; Vasconcellos, D. Silvade.. - p. 1-4 , 2023

Link: https://doi.org/10.1109/..

3

P140 Immunomodulators are protective against severe COVID 1..:

Vuitton, L ; Bourrier, A ; Uzzan, M...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i222-i223 , 2022

Link: https://doi.org/10.1093/..

4

P504 Effectiveness and safety of ustekinumab maintenance th..:

Fumery, M ; Filippi, J ; Abitbol, V...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S486-S487 , 2021

Link: https://doi.org/10.1093/..

5

Vascularites à IgA associées aux maladies inflammatoires ch..:

Rasmussen, C. ; Abitbol, V. ; El Karoui, K....
La Revue de Médecine Interne. 41 (2020) - p. A24-A25 , 2020

Link: https://doi.org/10.1016/..

6

P248 Validation of IBD-disk for the assessment of daily-lif..:

Tadbiri, S ; Nachury, M ; Bouhnik, Y...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S272-S272 , 2020

Link: https://doi.org/10.1093/..

7

P719 Effectiveness and safety of ustekinumab induction ther..:

Amiot, A ; Vered, A ; Filippi, J...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S579-S579 , 2020

Link: https://doi.org/10.1093/..

8

P020 MAM, an anti-inflammatory protein derived from Faecali..:

McLellan, P ; Lavelle, A ; Brot, L...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S140-S141 , 2020

Link: https://doi.org/10.1093/..

9

P413 A simple scoring tool predicts exposure–response relat..:

Dulai, P S ; Amiot, A ; Peyrin-Biroulet, L...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S316-S316 , 2019

Link: https://doi.org/10.1093/..

10

P711 The real-life experience of vedolizumab therapy in the..:

Amiot, A ; Serrero, M ; Peyrin-Biroulet, L...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S476-S477 , 2019

Link: https://doi.org/10.1093/..

11

P199 Hidradenitis suppurativa associated with Crohn's disea..:

Dumont, L -M ; Guegan-Bart, S ; Landman, C...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S199-S199 , 2018

Link: https://doi.org/10.1093/..

12

Long‐term efficacy and safety of ustekinumab in 122 refract..:

Wils, P. ; Bouhnik, Y. ; Michetti, P....
Alimentary Pharmacology & Therapeutics. 47 (2018) 5 - p. 588-595 , 2018

Link: https://doi.org/10.1111/..

13

P345 Impact of aphthous colitis at diagnosis on Crohn's dis..:

Delattre, C ; Nion-Larmurier, I ; Bourrier, A...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S277-S277 , 2018

Link: https://doi.org/10.1093/..

14

One‐year effectiveness and safety of vedolizumab therapy fo..:

Amiot, A. ; Serrero, M. ; Peyrin‐Biroulet, L....
Alimentary Pharmacology & Therapeutics. 46 (2017) 3 - p. 310-321 , 2017

Link: https://doi.org/10.1111/..

15

Impact of vedolizumab therapy on extra‐intestinal manifesta..:

Tadbiri, S. ; Peyrin‐Biroulet, L. ; Serrero, M....
Alimentary Pharmacology & Therapeutics. 47 (2017) 4 - p. 485-493 , 2017

Link: https://doi.org/10.1111/..